About 100 reports

  • 11: Prescription Skin Cancer Drugs
  • COMMON PRESCRIPTION TOPICAL, INTRALESIONAL AND OTHER SKIN CANCER AGENTS
  • Cancer
  • Dermatological Condition
  • Therapy
  • World
  • Merck & Co., Inc.
  • Five forces analysis

This type of cancer is further categorized by the affected areas such as oral cavity cancer, laryngeal cancer, pharyngeal cancer and other head and neck cancer.

  • Cancer
  • Ear, Nose, And Throat Medicine
  • World
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Cancer supportive care market in EMEA
  • 3.2 Information sources
  • Cancer
  • Therapy
  • Amgen Inc.
  • Helsinn Group
  • Merck & Co., Inc.
  • 4.2 CERVICAL CANCER/ HPV - ADULT VACCINE ANALYSIS AND FORECAST (2007
  • 4.2.1 CERVICAL CANCER/ HPV - ADULT VACCINE MARKET AND FORECAST
  • Cancer
  • Infectious Disease
  • Vaccine
  • Demand
  • Merck & Co., Inc.
  • Executive Summary
  • Untitled

High-risk HPV types cause approximately ##% of all cancers worldwide - it is thought to account for ##% of anal cancers, ##% of oropharyngeal cancers, ##% of vaginal cancers, ##% of vulvar cancers, and ##% of penile cancers.

  • Cancer
  • Cancer Immunotherapy
  • Therapy
  • Vaccine
  • Merck & Co., Inc.
  • 10.3 ADVAXIS
  • 10.26 ONCOTHYREON

CANCER VACCINES MARKET - REGIONAL ANALYSIS TO 2020 United States - Cancer Vaccines Market Europe - Cancer Vaccines Market Asia - Cancer Vaccines Market ##.

  • Cancer
  • Cancer Immunotherapy
  • Therapy
  • Vaccine
  • Merck & Co., Inc.
  • Stages of bladder cancer
  • Bladder cancer therapeutics market in Americas
  • Cancer
  • United States
  • Forecast
  • Market Size
  • Merck & Co., Inc.
  • LUNG CANCER THERAPEUTICS MARKET IN EMEA
  • MARKET PENETRATION OF VARIOUS LUNG CANCER THERAPEUTICS MANUFACTURERS IN GLOBAL (2015)
  • Cancer
  • Lung Cancer
  • AstraZeneca PLC
  • Celgene Corporation
  • Merck & Co., Inc.
  • COLORECTAL CANCER: KEY METRICS IN SEVEN MAJOR PHARMACEUTICAL MARKETS
  • MODERATE GROWTH IN THE COLORECTAL CANCER MARKET EXPECTED FROM 2015 THROUGH 2025
  • Cancer
  • Colorectal Cancer
  • Hospital
  • Therapy
  • Merck & Co., Inc.
  • 8.1 References
  • UROLOGIC ONCOLOGY THERAPEUTICS MARKET, GLOBAL, FORECAST MARKET SHARE BY

Male-specific cancers, such as prostate, testicular and penile cancer, are classed as urological cancers.

  • Cancer
  • Therapy
  • Urology
  • Merck & Co., Inc.
  • Pfizer Inc.

TYPES AND SYMPTOMS OF SKIN CANCER SKIN CANCER ACCOUNTS FOR OVER ##% OF ALL CANCERS.

  • Autoimmune Disease
  • Cancer
  • Dermatological Condition
  • Dermatology
  • Merck & Co., Inc.
  • GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET
  • Pipeline portfolio
  • Cancer
  • Cancer Immunotherapy
  • Therapy
  • Market Size
  • Merck & Co., Inc.
  • 8.1 References
  • Oncology, Global, All Clinical Stage Pipeline Products, 2016

Cancer surgery: Physically removing cancer.

  • Cancer
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • Breast Cancer Therapeutics Market, Global, Co-development Deals in Southeast Asia and Deals with Disclosed Values, 2006-
  • Breast Cancer Therapeutics Market, Global, All Pipeline Products, Phase I, 2016
  • Cancer
  • Asia
  • World
  • Market Size
  • Merck & Co., Inc.

MARKET DRIVERS Technological advancement Increased prevalence of cancer Cancer is one of the life-threating diseases worldwide.

  • Cancer
  • Transplantation
  • World
  • Forecast
  • Merck & Co., Inc.
  • JOHNSON & JOHNSON
  • COMPETITIVE SCENARIO

Approximately ##, ## people who have cancer died in the US in 2016.

  • Cancer
  • HIV AIDS
  • World
  • Forecast
  • Merck & Co., Inc.
  • DATE
  • Date

OTHERS INCLUDE BREAST CANCER, MELANOMA AND BLADDER CANCER.

  • Cancer
  • Infectious Disease
  • Monoclonal Antibody
  • Therapy
  • Merck & Co., Inc.
  • 2 Bladder Cancer: Executive Summary
  • BLADDER CANCER: KEY METRICS IN THE 7MM
  • Bladder Cancer
  • Cancer
  • Therapy
  • Europe
  • Merck & Co., Inc.
  • Executive Summary
  • EARLY-STAGE CLINICAL DEVELOPMENT IN NSCLC

CANCER.

  • Cancer
  • Hospital
  • Lung Cancer
  • Therapy
  • Merck & Co., Inc.
  • COMPETITIVE LANDSCAPE

ACCORDING TO THE INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, BREAST CANCER IS THE SECOND MOST COMMON CANCER IN THE WORLD, WITH AN ESTIMATED ##. ## MILLION NEW CANCER CASES DIAGNOSED IN 2012 (##% OF ALL CANCERS).

  • Cancer
  • Laboratory
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • Merck & Co., Inc.
  • Gastric Cancer Therapeutics Market, Global, All Pipeline Products, Phase III, 2016
  • Executive Summary
  • Cancer
  • Gastric Cancer
  • Therapy
  • Merck & Co., Inc.
  • Roche Group
  • EARLY-STAGE IMMUNE CHECKPOINT INHIBITORS
  • PRODUCT PROFILE - KEYTRUDA
  • Cancer
  • Chemotherapy
  • Gastric Cancer
  • Therapy
  • Merck & Co., Inc.
  • TREATING LUNG CANCER
  • Novel Therapies in Breast Cancer Treatment
  • Cancer
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • Novartis AG
  • 8. Global Renal Cell Carcinoma Drugs Market - Company Wise Pipeline Analysis
  • 8.1 MERCK & CO., INC.
  • Cancer
  • Renal Cancer
  • Targeted Therapy
  • Exelixis, Inc.
  • Merck & Co., Inc.

Introduction ## ##. ## Introduction to Skin Cancer ## ##. ##. ## Skin Cancer ## ##. ##. ## Types of Skin Cancer ## ##. ## Introduction to Malignant Melanoma Skin Cancer ## ##. ##. ## Malignant Melanoma Skin Cancer ## ##. ##. ## Risk Factors of Malignant Melanoma Skin

  • Cancer
  • Skin Cancer
  • Market Size
  • Biopharmaceuticals Inc.
  • Merck & Co., Inc.
  • 9 Promising Approaches in Early-Stage Development
  • NOVARTIS SWOT ANALYSIS IN RCC, 2014

CANCERS OF THE GENITOURINARY SYSTEM: CANCER OF THE KIDNEY.

  • Cancer
  • Epidemiology
  • Renal Cancer
  • Therapy
  • Merck & Co., Inc.

Gastric cancer

4546 5000 3864
  • Pipeline: Gastric Cancer
  • Forecast: Gastric Cancer
  • Cancer
  • Chemotherapy
  • Gastric Cancer
  • Therapy
  • Merck & Co., Inc.
  • Guangzhou Medical University
  • 9.1.4 PHASE I

Lung cancer is the most common cancer type in males.

  • Cancer
  • Lung Cancer
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • 9.1.3 INVESTIGATIONAL NEW DRUG/CLINICAL TRIAL AUTHORIZATION-FILED
  • Introduction

Colorectal cancer (bowel cancer).

  • Cancer
  • Colorectal Cancer
  • World
  • Market Size
  • Merck & Co., Inc.
  • human cancers
  • 5.3.6 VASCULAR ENDOTHELIAL GROWTH FACTOR
  • Cancer
  • Monoclonal Antibody
  • Therapy
  • Merck & Co., Inc.
  • Novartis AG